Millennium Partners cash boosts liquidity at StemCells:
This article was originally published in Clinica
Millennium Partners has exercised an option to buy 457,750 shares of StemCells for a total of $2 million. In August 2000, the investment fund put $5 million into the Palo Alto, California-based company. StemCells said that this and other finance sources will allow it to speed up its internal R&D and in particular its neuronal stem cell programme.